AMP-activated Protein Kinase (AMPK) Activating Agents Cause Dephosphorylation of Akt and Glycogen Synthase Kinase-3

Overview

Journal Biochem Pharmacol

Specialties Biochemistry
Pharmacology

Date 2006 Apr 20

PMID 16620785

Citations 57

Authors

Taj D King

Ling Song

Richard S Jope

Affiliations

Soon will be listed here.

Abstract

AMP-activated protein kinase (AMPK) is a key cellular sensor of reduced energy supply that is activated by increases in the cellular ratio of AMP/ATP. Phenformin and 5-aminoimidazole-4-carboxamide riboside (AICAR) are two drugs widely used to activate AMPK experimentally. In both differentiated hippocampal neurons and neuroblastoma SH-SY5Y cells we found that these two agents not only activated AMPK, but conversely greatly reduced the activating Ser/Thr phosphorylation of Akt. This blockade of Akt activity consequently lowered the inhibitory serine-phosphorylation of its substrates, glycogen synthase kinase-3alpha/beta (GSK3alpha/beta). An inhibitor of AMPK (Compound C) did not block dephosphorylation of Akt and GSK3. Thus, both drugs widely used to activate AMPK also caused dephosphorylation of Akt and of GSK3. The mechanism for Akt dephosphorylation caused by phenformin, but not AICAR, was due to inhibition of growth factor-induced signaling that leads to Akt phosphorylation. Stimulation of muscarinic receptors with carbachol in SH-SY5Y cells also activated AMPK and transiently caused dephosphorylation of Akt. These findings show that Akt dephosphorylation often occurs concomitantly with AMPK activation when cells are treated with phenformin or AICAR, indicating that these drugs do not only affect AMPK but also cause a coordinated inverse regulation of AMPK and Akt.

Citing Articles

Insulin signaling disruption exacerbates memory impairment and seizure susceptibility in an epilepsy model with Alzheimer's disease-like pathology.

Alves S, Servilha-Menezes G, Rossi L, Cortes de Oliveira J, Grigorio-de-SantAna M, Sebollela A J Neural Transm (Vienna). 2025; .

PMID: 39987343 DOI: 10.1007/s00702-025-02896-1.

Loss of protects against MASLD alone or with alcohol intake by preserving lipid homeostasis.

Lamas-Paz A, Hionides-Gutierrez A, Guo F, Jorquera G, Moran-Blanco L, Benede-Ubieto R JHEP Rep. 2024; 7(1):101230.

PMID: 39659733 PMC: 11629569. DOI: 10.1016/j.jhepr.2024.101230.

Mito-LND and (E)-Akt inhibitor-IV: novel compounds inducing endoplasmic reticulum stress and ROS accumulation against hepatocellular carcinoma.

Liao S, Wang Q, Chen S, Huang Q, Zhou L, Liu H J Transl Med. 2024; 22(1):792.

PMID: 39198815 PMC: 11351498. DOI: 10.1186/s12967-024-05545-5.

The clinical antiprotozoal drug nitazoxanide and its metabolite tizoxanide extend lifespan and healthspan.

Li W, Chen S, Lang J, Luo J, Chen J, Zhang L Acta Pharm Sin B. 2024; 14(7):3266-3280.

PMID: 39027239 PMC: 11252460. DOI: 10.1016/j.apsb.2024.03.031.

The interplay of mitophagy, autophagy, and apoptosis in cisplatin-induced kidney injury: involvement of ERK signaling pathway.

Suman I, Simic L, canadi Juresic G, Buljevic S, Klepac D, Domitrovic R Cell Death Discov. 2024; 10(1):98.

PMID: 38402208 PMC: 10894217. DOI: 10.1038/s41420-024-01872-0.

References

Jope R, Johnson G . The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci. 2004; 29(2):95-102. DOI: 10.1016/j.tibs.2003.12.004. View

Morioka K, Nakatani K, Matsumoto K, Urakawa H, Kitagawa N, Katsuki A . Metformin-induced suppression of glucose-6-phosphatase expression is independent of insulin signaling in rat hepatoma cells. Int J Mol Med. 2005; 15(3):449-52. View

Grimes C, Jope R . The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol. 2001; 65(4):391-426. DOI: 10.1016/s0301-0082(01)00011-9. View

Meisse D, Van de Casteele M, Beauloye C, Hainault I, Kefas B, Rider M . Sustained activation of AMP-activated protein kinase induces c-Jun N-terminal kinase activation and apoptosis in liver cells. FEBS Lett. 2002; 526(1-3):38-42. DOI: 10.1016/s0014-5793(02)03110-1. View

Stefanelli C, Stanic I, Bonavita F, Flamigni F, Pignatti C, Guarnieri C . Inhibition of glucocorticoid-induced apoptosis with 5-aminoimidazole-4-carboxamide ribonucleoside, a cell-permeable activator of AMP-activated protein kinase. Biochem Biophys Res Commun. 1998; 243(3):821-6. DOI: 10.1006/bbrc.1998.8154. View

Grahame Hardie D . The AMP-activated protein kinase pathway--new players upstream and downstream. J Cell Sci. 2004; 117(Pt 23):5479-87. DOI: 10.1242/jcs.01540. View

Russell 3rd R, Li J, Coven D, Pypaert M, Zechner C, Palmeri M . AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J Clin Invest. 2004; 114(4):495-503. PMC: 503766. DOI: 10.1172/JCI19297. View

Carling D . The AMP-activated protein kinase cascade--a unifying system for energy control. Trends Biochem Sci. 2004; 29(1):18-24. DOI: 10.1016/j.tibs.2003.11.005. View

Garcia-Gil M, Pesi R, Perna S, Allegrini S, Giannecchini M, Camici M . 5'-aminoimidazole-4-carboxamide riboside induces apoptosis in human neuroblastoma cells. Neuroscience. 2003; 117(4):811-20. DOI: 10.1016/s0306-4522(02)00836-9. View

10.

Lawlor M, Alessi D . PKB/Akt: a key mediator of cell proliferation, survival and insulin responses?. J Cell Sci. 2001; 114(Pt 16):2903-10. DOI: 10.1242/jcs.114.16.2903. View

11.

Henin N, Vincent M, Gruber H, Van den Berghe G . Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP-activated protein kinase. FASEB J. 1995; 9(7):541-6. DOI: 10.1096/fasebj.9.7.7737463. View

12.

Fryer L, Carling D . The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J Biol Chem. 2002; 277(28):25226-32. DOI: 10.1074/jbc.M202489200. View

13.

Ido Y, Carling D, Ruderman N . Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation. Diabetes. 2002; 51(1):159-67. DOI: 10.2337/diabetes.51.1.159. View

14.

Kefas B, Cai Y, Kerckhofs K, Ling Z, Martens G, Heimberg H . Metformin-induced stimulation of AMP-activated protein kinase in beta-cells impairs their glucose responsiveness and can lead to apoptosis. Biochem Pharmacol. 2004; 68(3):409-16. DOI: 10.1016/j.bcp.2004.04.003. View

15.

Kim Y, Ciaraldi T, Kong A, Kim D, Chu N, Mohideen P . Troglitazone but not metformin restores insulin-stimulated phosphoinositide 3-kinase activity and increases p110beta protein levels in skeletal muscle of type 2 diabetic subjects. Diabetes. 2002; 51(2):443-8. DOI: 10.2337/diabetes.51.2.443. View

16.

Jung J, Lee J, Ha J, Kim S, Cho Y, Baik H . 5-Aminoimidazole-4-carboxamide-ribonucleoside enhances oxidative stress-induced apoptosis through activation of nuclear factor-kappaB in mouse Neuro 2a neuroblastoma cells. Neurosci Lett. 2004; 354(3):197-200. DOI: 10.1016/j.neulet.2003.10.012. View

17.

Bijur G, Jope R . Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3-kinase activation. J Neurochem. 2004; 87(6):1427-35. PMC: 2040497. DOI: 10.1046/j.1471-4159.2003.02113.x. View

18.

Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J . Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 2001; 108(8):1167-74. PMC: 209533. DOI: 10.1172/JCI13505. View

19.

Al-Khalili L, Chibalin A, Yu M, Sjodin B, Nylen C, Zierath J . MEF2 activation in differentiated primary human skeletal muscle cultures requires coordinated involvement of parallel pathways. Am J Physiol Cell Physiol. 2004; 286(6):C1410-6. DOI: 10.1152/ajpcell.00444.2003. View

20.

Corton J, Gillespie J, Hawley S, Hardie D . 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?. Eur J Biochem. 1995; 229(2):558-65. DOI: 10.1111/j.1432-1033.1995.tb20498.x. View